Community Oncology
We're investing in the future of community oncology.
When community practices thrive, so does the care for millions of cancer patients. From our earliest days, we have been focused on the long-term success of community oncology.
The leading technology platform in community oncology
Our OncoCloudTM suite is built to meet the technology needs of the community practice of the future: operationally efficient and prepared to thrive in the world of value-based care.
Over 2,600 clinicians at more than 800 sites across the country have chosen Flatiron as their long-term technology partner.
- The OncoCloudTM suite has been ranked the #1 end-to-end oncology technology solution by Black Book Research.
- OncoEMR® is top-rated for overall satisfaction by KLAS’ 2019 Medical Oncology Performance Report.
Our OncoCloud™ suite
MIPS & OCM support you deserve
Value-based care
Declining reimbursement rates, increased patient loads and regulatory changes are a difficult reality for many clinics. It’s no surprise that so many find it challenging to remain financially viable while delivering the best care possible. Flatiron’s OncoCloudTM products can help.
Learn more
Implementing remote care in response to COVID-19: NYCBS and Flatiron Revenue Cycle Management
See case studyIn our previous system, it took 23 steps to schedule a patient. Now it takes less than half of that.
Practices in our network include:
Let us tell you more.
We will email you to start the conversation.
Flatiron Health, Foundation Medicine and Genentech Partner to Launch Novel Prospective Lung Cancer Clinical Study
The Prospective Clinico-Genomic Study will pilot the use of a technology-enabled prospective data collection platform to facilitate, streamline and simplify the execution of clinical trials for patients living with advanced lung cancer.
An emerging story: What data tell us about the impact of COVID-19 in community oncology
Chief Medical Officer Dr. Bobby Green on the data revealing trends and challenges that community oncology will face in the coming months.
The Oncology Care First model: A new paradigm in cancer care payment
Ryan Holleran, who oversees Flatiron’s quality and cost of care initiatives, discusses how Medicare’s new Oncology Care First model will impact the cancer reimbursement landscape.